Principal Street Partners, LLC Astrazeneca PLC Transaction History

Principal Street Partners, LLC

$615 Million
Q3 2024

A detailed history of Principal Street Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Principal Street Partners, LLC holds 18,134 shares of AZN stock, worth $1.22 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

18,134

Previous 9,148 98.23%

Holding current value

$1.22 Million

Previous $713,000 98.18%

% of portfolio

0.23%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $688,956 - $787,353	8,986 Added 98.23%	18,134 $1.41 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $27,280 - $31,097	447 Added 5.14%	9,148 $619,000
Q4 2023 Feb 07, 2024	SELL	$61.89 - $69.28 $579,847 - $649,084	-9,369 Reduced 51.85%	8,701 $586,000
Q3 2023 Nov 01, 2023	BUY	$64.85 - $71.7 $602,326 - $665,949	9,288 Added 105.76%	18,070 $1.22 Million
Q2 2023 Aug 21, 2023	BUY	$69.91 - $75.81 $4,753 - $5,155	68 Added 0.78%	8,782 $628,000
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $20,018 - $22,697	-317 Reduced 3.51%	8,714 $604,000
Q4 2022 Feb 15, 2023	SELL	$54.21 - $70.44 $38,760 - $50,364	-715 Reduced 7.34%	9,031 $612,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $14,368 - $36,788	-271 Reduced 2.71%	9,746 $534,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $16,592 - $19,919	280 Added 2.88%	10,017 $662,000
Q1 2022 May 05, 2022	BUY	$55.72 - $67.12 $542,545 - $653,547	9,737 New	9,737 $646,000
Q4 2021 Feb 07, 2022	SELL	$54.02 - $63.83 $485,207 - $573,321	-8,982 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $146,900 - $160,728	2,644 Added 41.72%	8,982 $539,000
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $21,111 - $26,238	436 Added 7.39%	6,338 $380,000
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $2,216 - $2,558	47 Added 0.8%	5,902 $293,000
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $310,724 - $357,740	5,855 New	5,855 $321,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $351,135 - $450,610	-8,147 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $1,444 - $1,636	36 Added 0.44%	8,147 $363,000
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $302,378 - $338,066	8,111 New	8,111 $335,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $209B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principal Street Partners, LLC with notifications on news.

Account

Principal Street Partners, LLC Astrazeneca PLC Transaction History